Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Albert Alahmar , Anthony H Gershlick Added: 3 years ago
Drug-eluting stents (DES) have revolutionized the field of interventional cardiology. The US Food and Drug Administration (FDA) is expecting that the total number of DES implanted in 2010 will surpass 5 million worldwide. Although initial results seemed promising, longer-term follow-up in a wider range of patients revealed some concerns. Enhanced platelet aggregation, delayed neointimal growth, a… View more

Intervention
Author(s): Giora Weisz Added: 3 years ago
Much has been written, but little is known, about the long-term outcomes after drug-eluting stent (DES). The introduction of DES has extended the use of stents from a passive platform for vessel wall scaffolding to an active biotechnology vehicle for local delivery of antiproliferative pharmacotherapy. Like any other therapy or medical technology, no treatment is perfect and free of potential… View more

Intervention
Author(s): Peter J Fitzgerald , Martin B Leon Added: 3 years ago
An unintended consequence of the market success of drug-eluting stents has been a growing concern about their safety and safety-related costs. These devices have been so quickly and widely adopted that their market penetration already equals that of some of the most popular pharmaceutical drugs. Consequently, the absolute significance of even a low incidence of side effects becomes magnified by… View more

Intervention
Author(s): Peter J Fitzgerald , Martin B Leon Added: 3 years ago
An unintended consequence of the market success of drug-eluting stents has been a growing concern about their safety and safety-related costs. These devices have been so quickly and widely adopted that their market penetration already equals that of some of the most popular pharmaceutical drugs. Consequently, the absolute significance of even a low incidence of side effects becomes magnified by… View more

Intervention
Author(s): David Holmes Jr Added: 3 years ago
Percutaneous coronary revascularization has revolutionized modern cardiovascular care. It has become one of the most well-studied and frequently performed procedures in modern medicine and is currently performed in more than 900,000 patients per year, exceeding the rate of coronary bypass surgery. It is used in an increasingly large number of patient subsets and used to treat an increasingly… View more

Intervention
Research Area(s) / Expertise: Job title: Professor of Medicine
Dr Martin B. Leon is a prominent figure in the field of interventional cardiovascular medicine, contributing significantly to the industry. Currently serving as the Professor of Medicine at Columbia University Irving Medical Center, he has held key roles such as the Director of the Columbia Interventional Cardiovascular Care and, until July 2023, Director of the Cardiovascular Data Science Center… View more
Author(s): Michael Megaly , Marwan Saad , Emmanouil S Brilakis Added: 3 years ago
Percutaneous coronary intervention (PCI) of small-vessel coronary artery disease (SVD) is challenging because of difficulties with equipment delivery and high restenosis rates. Drug-coated balloons (DCBs) are an attractive emerging PCI option for patients with SVD. Small-vessel coronary artery disease SVD was defined in the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small… View more

Prevention & Chronic Conditions
Added: 3 years ago
Doctors Proactive in Pre-diagnosis Treatment of Heart Attacks Doctors are treating patients with a suspected heart attack as aggressively as they are patients who have been diagnosed with an attack. Researchers from Wake Forest University School of Medicine analyzed patient data from over 450 hospitals in 12 countries. They compared the treatment received by patients with different levels of… View more

Standards & Guidelines
Job title: Head, Product Development Team, Drug-eluting Stents
Job title: Interventional Cardiologist
DrMichael Haude is anInterventional Cardiologist atRheinlandklinkum, Neuss, DE. He is President of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Board Member of the European Society of Cardiology (ESC). Dr Haude's interests include drug eluting stents, bioresorbable scaffolds, complex PCI, structural heart disease intervention and complication management… View more